Alfresa Holdings Corporation operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alfresa Holdings with three other
companies in this sector in Japan:
Toho Holdings Company Limited
sales of 1.23 trillion Japanese Yen [US$11.08 billion]
of which 92%
was Pharmaceutical Wholesale Business),
Medipal Holdings Corporation
(3.06 trillion Japanese Yen [US$27.58 billion]
of which 68%
was Pharmaceuticals And Food Precessing Whol), and
Suzuken Co., Ltd.
(2.13 trillion Japanese Yen [US$19.14 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended March of 2017, sales at
Alfresa Holdings were ¥2.55 trillion (US$22.97 billion).
decrease of 1.0%
versus 2016, when the company's sales were ¥2.58 trillion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Alfresa Holdings had sales
of ¥2.33 trillion.
Contributing to the drop in overall sales was the 3.3% decline
in Other Businesses, from ¥31.32 billion to ¥30.27 billion.
There were also decreases in sales in
Wholesale Business of Pharmaceuticals Fo (down 1.7% to ¥2.24 trillion)
However, these declines were partially offset by the increase in sales of
Wholesale Business of Self-Medication (up 2.4% to ¥249.95 billion)
Manufacturing Pharmaceuticals, Etc. (up 45.4% to ¥32.09 billion)